GM Helix Implant, Endosseous Dental Implant Article No. 109.984
FDA Device Recall #Z-2929-2026 - Class II, July 13, 2026
Recall Summary
| Recall Number | Z-2929-2026 |
| Classification | Class II - Moderate risk |
| Date Initiated | July 13, 2026 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Straumann USA LLC |
| Location | Andover, MA |
| Product Type | Devices |
| Quantity | 417 US |
Product Description
GM Helix Implant, Endosseous Dental Implant Article No. 109.984
Reason for Recall
There may be a mismatch between the implant contained inside the packaging and the information described on the outer carton label. If the the incorrect implant is installed, the issue could cause bone compression or difficulty during installation in situations where there is sufficient bone volume
Distribution Pattern
US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MO, MS, MT, NC, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI.
Lot / Code Information
UDI-DI 7899878024552 Lot MVXJ9
Other Recalls from Straumann USA LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2935-2026 | Class II | Straumann Bone Level Tapered (BLT) Implant, D 4... | Jul 16, 2026 |
| Z-1994-2026 | Class II | Straumann n!ce PMMA Full-arch Restoration. Scre... | Mar 27, 2026 |
| Z-1995-2026 | Class II | Straumann n!ce Zr, HT, Full-arch Restoration. A... | Mar 27, 2026 |
| Z-1632-2026 | Class II | Custom Abutment Ti, for Straumann RC, incl. TAN... | Mar 17, 2026 |
| Z-1633-2026 | Class II | Custom Abutment AS Ti, for Straumann RC, incl. ... | Mar 17, 2026 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.